Literature DB >> 23229652

Effects of amino acids and albumin on erythropoietin carbamoylation.

Kyubok Jin1.   

Abstract

BACKGROUND: Anemia in chronic renal failure results from inadequate production of erythropoietin and decrease in its biological activity, and the reduced activity of erythropoietin is caused by the presence of plasma inhibitors of erythropoietin. It is reported that one of the inhibitors of erythropoietin is cyanate, a potential uremic toxin formed spontaneously from increased urea due to decreased renal function, and erythropoietin loses its biological activity due to negatively charged cyanate. The purpose of this study is to investigate the protective effects of amino acids, positively charged amino groups, and albumin binding of several toxins on erythropoietin carbamoylation.
METHODS: The degree of change in erythropoietin structure by cyanate was measured by the trinitrobenzenesulphonate reaction and Western blotting. The loss of biological activity of erythropoietin caused by cyanate was measured by injecting erythropoietin into rats with chronic renal failure.
RESULTS: The free amino groups in erythropoietin decreased under cyanate treatment in a time- and concentration-dependent manner. In the cyanate treatment group, of the twenty amino acids, phenylalanine, valine, tryptophan, threonine, and lysine prevented the structural modification of erythropoietin, according to Western blot analysis. In addition, of the three proteins, albumin prevented the structural modification of erythropoietin. As for the cyanate with erythropoietin treatment group, only lysine and albumin prevented the loss of biological activity of erythropoietin in the rats.
CONCLUSION: The results of this study suggest that lysine and albumin may play a protective role against renal anemia by erythropoietin carbamoylation in chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23229652     DOI: 10.1007/s10157-012-0751-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  23 in total

Review 1.  Review on uremic toxins: classification, concentration, and interindividual variability.

Authors:  Raymond Vanholder; Rita De Smet; Griet Glorieux; Angel Argilés; Ulrich Baurmeister; Philippe Brunet; William Clark; Gerald Cohen; Peter Paul De Deyn; Reinhold Deppisch; Beatrice Descamps-Latscha; Thomas Henle; Achim Jörres; Horst Dieter Lemke; Ziad A Massy; Jutta Passlick-Deetjen; Mariano Rodriguez; Bernd Stegmayr; Peter Stenvinkel; Ciro Tetta; Christoph Wanner; Walter Zidek
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

2.  Cyanate derived from urea in uraemia.

Authors:  J J Harding
Journal:  Lancet       Date:  1992-02-22       Impact factor: 79.321

3.  ON THE REVERSIBLE REACTION OF CYANATE WITH SULFHYDRYL GROUPS AND THE DETERMINATION OF NH2-TERMINAL CYSTEINE AND CYSTINE IN PROTEINS.

Authors:  G R STARK
Journal:  J Biol Chem       Date:  1964-05       Impact factor: 5.157

4.  Chemical modification of erythropoietin: an increase in in vitro activity by guanidination.

Authors:  R Satake; H Kozutsumi; M Takeuchi; K Asano
Journal:  Biochim Biophys Acta       Date:  1990-03-29

Review 5.  Managing the burden of chronic kidney disease.

Authors:  Micah L Thorp; Loris Eastman; David H Smith; Eric S Johnson
Journal:  Dis Manag       Date:  2006-04

6.  Plasma cyanate concentrations in chronic renal failure.

Authors:  L Nilsson; P Lundquist; B Kågedal; R Larsson
Journal:  Clin Chem       Date:  1996-03       Impact factor: 8.327

7.  Hemoglobin carbamylation in uremia.

Authors:  R Flückiger; W Harmon; W Meier; S Loo; K H Gabbay
Journal:  N Engl J Med       Date:  1981-04-02       Impact factor: 91.245

8.  Kinetics of carbamylated haemoglobin in acute renal failure.

Authors:  A Wynckel; C Randoux; H Millart; C Desroches; P Gillery; E Canivet; J Chanard
Journal:  Nephrol Dial Transplant       Date:  2000-08       Impact factor: 5.992

Review 9.  Carbamoylation of amino acids and proteins in uremia.

Authors:  L M Kraus; A P Kraus
Journal:  Kidney Int Suppl       Date:  2001-02       Impact factor: 10.545

10.  Inhibition of erythropoietin activity by cyanate.

Authors:  Kyung-Dae Park; Kyo-Cheol Mun; Eun-Ju Chang; Sung-Bae Park; Hyun-Chul Kim
Journal:  Scand J Urol Nephrol       Date:  2004
View more
  1 in total

Review 1.  Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD.

Authors:  Anna Pieniazek; Joanna Bernasinska-Slomczewska; Lukasz Gwozdzinski
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.